Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines

Nucleic Acids Research

Volumn 41, Issue 21, 2013, Pages

  Börner, Kathleen ^a   Niopek, Dominik ^a,b   Cotugno, Gabriella ^a,b,e   Kaldenbach, Michaela ^c   Pankert, Teresa ^a,b,d   Willemsen, Joschka ^b   Zhang, Xian ^d   Schürmann, Nina ^a,b   Mockenhaupt, Stefan ^a,b,h   Serva, Andrius ^b,d   Hiet, Marie Sophie ^b   Wiedtke, Ellen ^a,b   Castoldi, Mirco ^a,g   Starkuviene, Vytaute ^b   Erfle, Holger ^b   Gilbert, Daniel F ^d,f   Bartenschlager, Ralf ^b   Boutros, Michael ^b,d   Binder, Marco ^b   Streetz, Konrad ^c   Kräusslich, Hans Georg ^a,b   Grimm, Dirk ^a,b   more..

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e Genome Organization and Function ^*

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g HEINRICH HEINE UNIVERSITY   (Germany)

^h NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; COMPLEMENTARY DNA; LENTIVIRUS VECTOR; MESSENGER RNA; SHORT HAIRPIN RNA; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CODON; CONTROLLED STUDY; DNA INTEGRATION; EMBRYO; GENE SILENCING; GENE TARGETING; GENETIC ENGINEERING; GENETIC ENHANCEMENT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LENTIVIRINAE; LIVER; LIVER TOXICITY; MOUSE; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; RNA INTERFERENCE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ARGONAUTE PROTEINS; CELL LINE, TUMOR; DEPENDOVIRUS; GENE KNOCKDOWN TECHNIQUES; GENETIC VECTORS; HEK293 CELLS; HUMANS; LENTIVIRUS; LIVER; MICE; PHENOTYPE; PLASMIDS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSDUCTION, GENETIC;

EID: 84890012407     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt836     Document Type: Article

References (79)

1. Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E. and Mello, C.C. (1998) Potent and specific genetic interference by doublestranded RNA in Caenorhabditis elegans. Nature, 391, 806-811.
2. Castanotto, D. and Rossi, J.J. (2009) The promises and pitfalls of RNA-interference-based therapeutics. Nature, 457, 426-433.
3. Grimm, D., Streetz, K.L., Jopling, C.L., Storm, T.A., Pandey, K., Davis, C.R., Marion, P., Salazar, F. and Kay, M.A. (2006) Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature, 441, 537-541.
4. Grimm, D. (2011) The dose can make the poison: lessons learned from adverse in vivo toxicities caused by RNAi overexpression. Silence, 2, 8.
5. Ehlert, E.M., Eggers, R., Niclou, S.P. and Verhaagen, J. (2010) Cellular toxicity following application of adeno-associated viral vector-mediated RNA interference in the nervous system. BMC Neurosci., 11, 20.
6. Bish, L.T., Sleeper, M.M., Reynolds, C., Gazzara, J., Withnall, E., Singletary, G.E., Buchlis, G., Hui, D., High, K.A., Gao, G. et al. (2011) Cardiac gene transfer of short hairpin RNA directed against phospholamban effectively knocks down gene expression but causes cellular toxicity in canines. Hum. Gene Ther., 22, 969-977.
7. Ulusoy, A., Sahin, G., Bjorklund, T., Aebischer, P. and Kirik, D. (2009) Dose optimization for long-term rAAV-mediated RNA interference in the nigrostriatal projection neurons. Mol. Ther., 17, 1574-1584.
8. Martin, J.N., Wolken, N., Brown, T., Dauer, W.T., Ehrlich, M.E. and Gonzalez-Alegre, P. (2011) Lethal toxicity caused by expression of shRNA in the mouse striatum: implications for therapeutic design. Gene Ther., 18, 666-673.
9. Khodr, C.E., Sapru, M.K., Pedapati, J., Han, Y., West, N.C., Kells, A.P., Bankiewicz, K.S. and Bohn, M.C. (2011) An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neurons. Brain Res., 1395, 94-107.
10. Castanotto, D., Sakurai, K., Lingeman, R., Li, H., Shively, L., Aagaard, L., Soifer, H., Gatignol, A., Riggs, A. and Rossi, J.J. (2007) Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC. Nucleic Acids Res., 35, 5154-5164.
11. Vickers, T.A., Lima, W.F., Nichols, J.G. and Crooke, S.T. (2007) Reduced levels of Ago2 expression result in increased siRNA competition in mammalian cells. Nucleic Acids Res., 35, 6598-6610.
12. Koller, E., Propp, S., Murray, H., Lima, W., Bhat, B., Prakash, T.P., Allerson, C.R., Swayze, E.E., Marcusson, E.G. and Dean, N.M. (2006) Competition for RISC binding predicts in vitro potency of siRNA. Nucleic Acids Res., 34, 4467-4476.
13. Khan, A.A., Betel, D., Miller, M.L., Sander, C., Leslie, C.S. and Marks, D.S. (2009) Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat. Biotechnol., 27, 549-555.
14. Pan, Q., de Ruiter, P.E., von Eije, K.J., Smits, R., Kwekkeboom, J., Tilanus, H.W., Berkhout, B., Janssen, H.L. and van der Laan, L.J. (2011) Disturbance of the microRNA pathway by commonly used lentiviral shRNA libraries limits the application for screening host factors involved in hepatitis C virus infection. FEBS Lett., 585, 1025-1030.
15. Börner, K. and Grimm, D. (2010) Use of small RNAs for therapeutic gene silencing: risk versus benefit. Drug Disc. Today Technol., 7, e51-e57.
16. Diederichs, S., Jung, S., Rothenberg, S.M., Smolen, G.A., Mlody, B.G. and Haber, D.A. (2008) Coexpression of Argonaute-2 enhances RNA interference toward perfect match binding sites. Proc. Natl Acad. Sci. USA, 105, 9284-9289.
17. Grimm, D., Wang, L., Lee, J.S., Schurmann, N., Gu, S., Borner, K., Storm, T.A. and Kay, M.A. (2010) Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver. J. Clin. Invest., 120, 3106-3119.
18. Yi, R., Doehle, B.P., Qin, Y., Macara, I.G. and Cullen, B.R. (2005) Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs. RNA, 11, 220-226.
19. Yi, R., Qin, Y., Macara, I.G. and Cullen, B.R. (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev., 17, 3011-3016.
20. Ohrt, T., Merkle, D., Birkenfeld, K., Echeverri, C.J. and Schwille, P. (2006) In situ fluorescence analysis demonstrates active siRNA exclusion from the nucleus by Exportin 5. Nucleic Acids Res., 34, 1369-1380.
21. Zeng, Y., Yi, R. and Cullen, B.R. (2003) MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl Acad. Sci. USA, 100, 9779-9784.
22. Hock, J. and Meister, G. (2008) The Argonaute protein family. Genome Biol., 9, 210.
23. Liu, J., Carmell, M.A., Rivas, F.V., Marsden, C.G., Thomson, J.M., Song, J.J., Hammond, S.M., Joshua-Tor, L. and Hannon, G.J. (2004) Argonaute2 is the catalytic engine of mammalian RNAi. Science, 305, 1437-1441.
24. Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G. and Tuschl, T. (2004) Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell, 15, 185-197.
25. Schurmann, N., Trabuco, L.G., Bender, C., Russell, R.B. and Grimm, D. (2013) Molecular dissection of human Argonaute proteins by DNA shuffling. Nat. Struct. Mol. Biol., 20, 818-826.
26. Diederichs, S. and Haber, D.A. (2007) Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell, 131, 1097-1108.
27. Winter, J. and Diederichs, S. (2011) Argonaute proteins regulate microRNA stability: Increased microRNA abundance by Argonaute proteins is due to microRNA stabilization. RNA Biol., 8, 1149-1157.
28. Cheloufi, S., Dos Santos, C.O., Chong, M.M. and Hannon, G.J. (2010) A Dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature, 465, 584-589.
29. Cifuentes, D., Xue, H., Taylor, D.W., Patnode, H., Mishima, Y., Cheloufi, S., Ma, E., Mane, S., Hannon, G.J., Lawson, N.D. et al. (2010) A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science, 328, 1694-1698.
30. Yang, J.S., Maurin, T., Robine, N., Rasmussen, K.D., Jeffrey, K.L., Chandwani, R., Papapetrou, E.P., Sadelain, M., O'Carroll, D. and Lai, E.C. (2010) Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis. Proc. Natl Acad. Sci. USA, 107, 15163-15168.
31. Gu, S., Jin, L., Zhang, F., Huang, Y., Grimm, D., Rossi, J.J. and Kay, M.A. (2011) Thermodynamic stability of small hairpin RNAs highly influences the loading process of different mammalian Argonautes. Proc. Natl Acad. Sci. USA, 108, 9208-9213.
32. Petri, S., Dueck, A., Lehmann, G., Putz, N., Rudel, S., Kremmer, E. and Meister, G. (2011) Increased siRNA duplex stability correlates with reduced off-target and elevated on-target effects. RNA, 17, 737-749.
33. Liu, Y.P., Schopman, N.C. and Berkhout, B. (2013) Dicerindependent processing of short hairpin RNAs. Nucleic Acids Res., 41, 3723-3733.
34. Charneau, P., Alizon, M. and Clavel, F. (1992) A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J. Virol., 66, 2814-2820.
35. Beer, S., Bellovin, D.I., Lee, J.S., Komatsubara, K., Wang, L.S., Koh, H., Borner, K., Storm, T.A., Davis, C.R., Kay, M.A. et al. (2010) Low-level shRNA cytotoxicity can contribute to MYCinduced hepatocellular carcinoma in adult mice. Mol. Ther., 18, 161-170.
36. Backes, P., Quinkert, D., Reiss, S., Binder, M., Zayas, M., Rescher, U., Gerke, V., Bartenschlager, R. and Lohmann, V. (2010) Role of annexin A2 in the production of infectious hepatitis C virus particles. J. Virol., 84, 5775-5789.
37. Samulski, R.J., Chang, L.S. and Shenk, T. (1987) A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol., 61, 3096-3101.
38. Tai, A.W., Benita, Y., Peng, L.F., Kim, S.S., Sakamoto, N., Xavier, R.J. and Chung, R.T. (2009) A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe, 5, 298-307.
39. Koutsoudakis, G., Kaul, A., Steinmann, E., Kallis, S., Lohmann, V., Pietschmann, T. and Bartenschlager, R. (2006) Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J. Virol., 80, 5308-5320.
40. Zufferey, R., Nagy, D., Mandel, R.J., Naldini, L. and Trono, D. (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol., 15, 871-875.
41. Grimm, D. (2002) Production methods for gene transfer vectors based on adeno-associated virus serotypes. Methods, 28, 146-157.
42. Castoldi, M., Schmidt, S., Benes, V., Hentze, M.W. and Muckenthaler, M.U. (2008) miChip: an array-based method for microRNA expression profiling using locked nucleic acid capture probes. Nat. Protoc., 3, 321-329.
43. Castoldi, M., Schmidt, S., Benes, V., Noerholm, M., Kulozik, A.E., Hentze, M.W. and Muckenthaler, M.U. (2006) A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA, 12, 913-920.
44. Keller, P., Toomre, D., Diaz, E., White, J. and Simons, K. (2001) Multicolour imaging of post-Golgi sorting and trafficking in live cells. Nat. Cell Biol., 3, 140-149.
45. Reiss, S., Rebhan, I., Backes, P., Romero-Brey, I., Erfle, H., Matula, P., Kaderali, L., Poenisch, M., Blankenburg, H., Hiet, M.S. et al. (2011) Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe, 9, 32-45.
46. Gilbert, D.F., Erdmann, G., Zhang, X., Fritzsche, A., Demir, K., Jaedicke, A., Muehlenberg, K., Wanker, E.E. and Boutros, M. (2011) A novel multiplex cell viability assay for high-throughput RNAi screening. PLoS One, 6, e28338.
47. Pau, G., Fuchs, F., Sklyar, O., Boutros, M. and Huber, W. (2010) EBImage-an R package for image processing with applications to cellular phenotypes. Bioinformatics, 26, 979-981.
48. Fuchs, F., Pau, G., Kranz, D., Sklyar, O., Budjan, C., Steinbrink, S., Horn, T., Pedal, A., Huber, W. and Boutros, M. (2010) Clustering phenotype populations by genome-wide RNAi and multiparametric imaging. Mol. Syst. Biol., 6, 370.
49. Erfle, H., Neumann, B., Rogers, P., Bulkescher, J., Ellenberg, J. and Pepperkok, R. (2008) Work flow for multiplexing siRNA assays by solid-phase reverse transfection in multiwell plates. J. Biomol. Screen., 13, 575-580.
50. Welker, R., Harris, M., Cardel, B. and Krausslich, H.G. (1998) Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: analysis of its role in enhancement of viral infectivity. J. Virol., 72, 8833-8840.
51. Rieber, N., Knapp, B., Eils, R. and Kaderali, L. (2009) RNAither, an automated pipeline for the statistical analysis of highthroughput RNAi screens. Bioinformatics, 25, 678-679.
52. Börner, K., Hermle, J., Sommer, C., Brown, N.P., Knapp, B., Glass, B., Kunkel, J., Torralba, G., Reymann, J., Beil, N. et al. (2010) From experimental setup to bioinformatics: an RNAi screening platform to identify host factors involved in HIV-1 replication. Biotechnol. J., 5, 39-49.
53. Grimm, D. and Kay, M.A. (2003) From virus evolution to vector revolution: use of naturally occurring serotypes of adenoassociated virus (AAV) as novel vectors for human gene therapy. Curr. Gene Ther., 3, 281-304.
54. Grimm, D., Lee, J.S., Wang, L., Desai, T., Akache, B., Storm, T.A. and Kay, M.A. (2008) In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses. J. Virol., 82, 5887-5911.
55. McCarty, D.M., Monahan, P.E. and Samulski, R.J. (2001) Selfcomplementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther., 8, 1248-1254.
56. Grimm, D. (2009) Asymmetry in siRNA design. Gene Ther., 16, 827-829.
57. Shan, G., Li, Y., Zhang, J., Li, W., Szulwach, K.E., Duan, R., Faghihi, M.A., Khalil, A.M., Lu, L., Paroo, Z. et al. (2008) A small molecule enhances RNA interference and promotes microRNA processing. Nat. Biotechnol., 26, 933-940.
58. Zhang, Q., Zhang, C. and Xi, Z. (2008) Enhancement of RNAi by a small molecule antibiotic enoxacin. Cell Res., 18, 1077-1079.
59. Deiters, A. (2010) Small molecule modifiers of the microRNA and RNA interference pathway. AAPS J., 12, 51-60.
60. Chen, C.M., Chiu, S.L., Shen, W. and Cline, H.T. (2009) Co-expression of Argonaute2 enhances short hairpin RNAinduced RNA interference in Xenopus CNS neurons in vivo. Front. Neurosci., 3, 63.
61. Shao, P.L., Lu, M.Y., Liau, Y.J., Chao, M.F., Chang, L.Y., Lu, C.Y., Kao, C.L., Chang, S.Y., Chi, Y.H. and Huang, L.M. (2011) Argonaute-2 enhances suppression of human cytomegalovirus replication by polycistronic short hairpin RNAs targeting UL46, UL70 and UL122. Antivir. Ther., 16, 741-749.
62. Mockenhaupt, S., Schurmann, N. and Grimm, D. (2011) When cellular networks run out of control: global dysregulation of the RNAi machinery in human pathology and therapy. Prog. Mol. Biol. Transl. Sci., 102, 165-242.
63. Bennasser, Y. and Jeang, K.T. (2006) HIV-1 Tat interaction with Dicer: requirement for RNA. Retrovirology, 3, 95.
64. Coley, W., Van Duyne, R., Carpio, L., Guendel, I., Kehn-Hall, K., Chevalier, S., Narayanan, A., Luu, T., Lee, N., Klase, Z. et al. (2010) Absence of DICER in monocytes and its regulation by HIV-1. J. Biol. Chem., 285, 31930-31943.
65. Triboulet, R., Mari, B., Lin, Y.L., Chable-Bessia, C., Bennasser, Y., Lebrigand, K., Cardinaud, B., Maurin, T., Barbry, P., Baillat, V. et al. (2007) Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science, 315, 1579-1582.
66. Casey Klockow, L., Sharifi, H.J., Wen, X., Flagg, M., Furuya, A.K., Nekorchuk, M. and de Noronha, C.M. (2013) The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection. Virology, 444, 191-202.
67. Adams, B.D., Claffey, K.P. and White, B.A. (2009) Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells. Endocrinology, 150, 14-23.
68. Zhang, X., Graves, P. and Zeng, Y. (2012) Overexpression of human Argonaute2 inhibits cell and tumor growth. Biochim. Biophys. Acta, 1830, 2553-2561.
69. Winter, J. and Diederichs, S. (2011) MicroRNA Northern blotting, precursor cloning, and Ago2-improved RNA interference. Methods Mol. Biol., 676, 85-100.
70. Zhang, X., Graves, P.R. and Zeng, Y. (2009) Stable Argonaute2 overexpression differentially regulates microRNA production. Biochim. Biophys. Acta, 1789, 153-159.
71. Landthaler, M., Gaidatzis, D., Rothballer, A., Chen, P.Y., Soll, S.J., Dinic, L., Ojo, T., Hafner, M., Zavolan, M. and Tuschl, T. (2008) Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs. RNA, 14, 2580-2596.
72. Parisi, C., Giorgi, C., Batassa, E.M., Braccini, L., Maresca, G., D'agnano, I., Caputo, V., Salvatore, A., Pietrolati, F., Cogoni, C. et al. (2011) Ago1 and Ago2 differentially affect cell proliferation, motility and apoptosis when overexpressed in SH-SY5Y neuroblastoma cells. FEBS Lett., 585, 2965-2971.
73. Detzer, A., Engel, C., Wunsche, W. and Sczakiel, G. (2011) Cell stress is related to re-localization of Argonaute 2 and to decreased RNA interference in human cells. Nucleic Acids Res., 39, 2727-2741.
74. Lund, E., Sheets, M.D., Imboden, S.B. and Dahlberg, J.E. (2011) Limiting Ago protein restricts RNAi and microRNA biogenesis during early development in Xenopus laevis. Genes Dev., 25, 1121-1131.
75. Cuccato, G., Polynikis, A., Siciliano, V., Graziano, M., di Bernardo, M. and di Bernardo, D. (2011) Modeling RNA interference in mammalian cells. BMC Syst. Biol., 5, 19.
76. Giering, J.C., Grimm, D., Storm, T.A. and Kay, M.A. (2008) Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic. Mol. Ther., 16, 1630-1636.
77. McBride, J.L., Boudreau, R.L., Harper, S.Q., Staber, P.D., Monteys, A.M., Martins, I., Gilmore, B.L., Burstein, H., Peluso, R.W., Polisky, B. et al. (2008) Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc. Natl Acad. Sci. USA, 105, 5868-5873.
78. Saayman, S., Arbuthnot, P. and Weinberg, M.S. (2010) Deriving four functional anti-HIV siRNAs from a single Pol III-generated transcript comprising two adjacent long hairpin RNA precursors. Nucleic Acids Res., 38, 6652-6663.
79. Scott, T., Paweska, J.T., Arbuthnot, P. and Weinberg, M.S. (2012) Pathogenic effects of Rift Valley fever virus NSs gene are alleviated in cultured cells by expressed antiviral short hairpin RNAs. Antivir. Ther., 17, 643-656.